Tumor Lysis Syndrome
📧 Sign up to get email alerts when something new happens for Tumor Lysis Syndrome.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2025-10-16FDA Approved: ALLOPURINOL — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA granted a supplemental approval for ALLOPURINOL submitted by Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals Inc. to update the prod…
-
FDA label_change · 2024-03-08FDA Approved: ALLOPURINOL — Supplemental Application (Harman Finochem Limited)
FDA approved a supplemental application for Allopurinol, approving changes to the labeling for Harman Finochem Limited's generic Allopurinol…
-
FDA label_change · 2024-01-29FDA Approved: ALLOPURINOL — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for Allopurinol submitted by Unichem Pharmaceuticals (USA), Inc., resulting in changes to the produc…
-
FDA label_change · 2019-04-23FDA Approved: ALLOPURINOL — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for allopurinol submitted by Zydus Lifesciences Limited, indicating changes to the product labeling.